Filed
by the Registrant ý
|
||
Filed
by a Party other than the Registrant o
|
||
Check
the appropriate box:
|
||
o
|
Preliminary
Proxy Statement
|
|
o
|
Confidential,
for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
o
|
Definitive
Proxy Statement
|
|
ý
|
Definitive
Additional Materials
|
|
o
|
Soliciting
Material Pursuant to Rule 14a-11(c) or Rule
14a-12
|
CYTORI
THERAPEUTICS, INC.
|
|||||
(Name
of Registrant as Specified In Its Charter)
|
|||||
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant)
|
|||||
Payment
of Filing Fee (Check the appropriate box):
|
|||||
ý
|
No
fee required
|
||||
o
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(4) and
0-11
|
||||
(1)
|
Title
of each class of securities to which transaction applies:
|
||||
(2)
|
Aggregate
number of securities to which transaction applies:
|
||||
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11:
|
||||
(4)
|
Proposed
maximum aggregate value of transaction:
|
||||
(5)
|
Total
fee paid:
|
||||
o
|
Fee
paid previously with preliminary materials.
|
||||
o
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
|
||||
(1)
|
Amount
Previously Paid:
|
||||
(2)
|
Form,
Schedule or Registration Statement No.:
|
||||
(3)
|
Filing
Party:
|
||||
(4)
|
Date
Filed:
|